Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey
- PMID: 821963
- DOI: 10.1210/jcem-43-3-638
Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey
Abstract
The effects of iv administration of L-dopa on serum prolactin were studied in both normal female rhesus monkeys and in monkeys in which the pituitary stalk had been previously sectioned. Revascularization of the pituitary gland was prevented by the insertion of a silastic barrier over the diaphragma sellae. Prolactin secretion was increased in all stalk-sectioned monkeys and, in contrast to intact animals, chlorpromazine administration was ineffective in further releasing prolactin. In both normal and stalk-sectioned monkeys, iv administration of L-dopa (3-120 mg) significantly inhibited prolactin release from the pituitary (P less than .005 normal; P less than .001 stalk section). L-dopa also suppressed the TRH-induced release of prolactin in both groups. These results indicate that L-dopa or dopamine may act directly on the anterior pituitary to inhibit prolactin secretion.
Similar articles
-
Effect of estrogen on thyrotropin-releasing hormone-induced release of prolactin in intact, ovariectomized, and stalk-sectioned female rhesus monkeys.Endocrinology. 1980 Jul;107(1):183-6. doi: 10.1210/endo-107-1-183. Endocrinology. 1980. PMID: 6769662
-
Differential sensitivity of prolactin release to dopamine and thyrotrophin-releasing hormone in intact and pituitary stalk-sectioned rhesus monkeys.J Endocrinol. 1980 Mar;84(3):479-87. doi: 10.1677/joe.0.0840479. J Endocrinol. 1980. PMID: 6771353
-
Failure of beta-endorphin to stimulate prolactin release in the pituitary stalk-sectioned monkey.Endocrinology. 1980 Dec;107(6):1663-6. doi: 10.1210/endo-107-6-1663. Endocrinology. 1980. PMID: 7428685
-
The effects of serotonin on prolactin and growth hormone concentrations in normal and pituitary stalk-sectioned monkeys.Endocrinology. 1980 Dec;107(6):1747-50. doi: 10.1210/endo-107-6-1747. Endocrinology. 1980. PMID: 7428689
-
L-DOPA and the control of prolactin secretion.Adv Neurol. 1974;5:447-56. Adv Neurol. 1974. PMID: 4216257 Review. No abstract available.
Cited by
-
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.Drugs. 1983 Apr;25(4):399-432. doi: 10.2165/00003495-198325040-00004. Drugs. 1983. PMID: 6133737 Review.
-
Amplification of LH response to LHRH by dopamine infusion in eugonadal women.J Endocrinol Invest. 1981 Jan-Mar;4(1):55-8. doi: 10.1007/BF03349415. J Endocrinol Invest. 1981. PMID: 6787110
-
[Hyperprolactinemia and sterility].Arch Gynecol. 1979 Jul 20;228(1-4):518-30. Arch Gynecol. 1979. PMID: 485455 German. No abstract available.
-
Metabolic clearance and production rates of prolactin in man.J Clin Invest. 1979 Dec;64(6):1669-80. doi: 10.1172/JCI109629. J Clin Invest. 1979. PMID: 583048 Free PMC article.
-
Neuroendocrine markers of CNS drug effects.Br J Clin Pharmacol. 1980 Jul;10(1):5-21. doi: 10.1111/j.1365-2125.1980.tb00497.x. Br J Clin Pharmacol. 1980. PMID: 6104974 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources